102 related articles for article (PubMed ID: 38772455)
1. Aspartic acid mutagenesis of αO-Conotoxin GeXIVA isomers reveals arginine residues crucial for inhibition of the α9α10 nicotinic acetylcholine receptor.
Luo A; He J; Yu J; Wu Y; Harvey PJ; Kasheverov IE; Kudryavtsev DS; McIntosh JM; Tsetlin VI; Craik DJ; Zhangsun D; Luo S
Int J Biol Macromol; 2024 May; 271(Pt 1):132472. PubMed ID: 38772455
[TBL] [Abstract][Full Text] [Related]
2. αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype.
Zhangsun D; Zhu X; Kaas Q; Wu Y; Craik DJ; McIntosh JM; Luo S
Neuropharmacology; 2017 Dec; 127():243-252. PubMed ID: 28416445
[TBL] [Abstract][Full Text] [Related]
3. Structure-Activity Relationships of Alanine Scan Mutants αO-Conotoxins GeXIVA[1,2] and GeXIVA[1,4].
Xu P; Zhang P; Zhu X; Wu Y; Harvey PJ; Kaas Q; Zhangsun D; Craik DJ; Luo S
J Med Chem; 2023 Jul; 66(14):10092-10107. PubMed ID: 37464764
[TBL] [Abstract][Full Text] [Related]
4. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.
Luo S; Zhangsun D; Harvey PJ; Kaas Q; Wu Y; Zhu X; Hu Y; Li X; Tsetlin VI; Christensen S; Romero HK; McIntyre M; Dowell C; Baxter JC; Elmslie KS; Craik DJ; McIntosh JM
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4026-35. PubMed ID: 26170295
[TBL] [Abstract][Full Text] [Related]
5. Structure and Activity Studies of Disulfide-Deficient Analogues of αO-Conotoxin GeXIVA.
Xu P; Kaas Q; Wu Y; Zhu X; Li X; Harvey PJ; Zhangsun D; Craik DJ; Luo S
J Med Chem; 2020 Feb; 63(4):1564-1575. PubMed ID: 31986036
[TBL] [Abstract][Full Text] [Related]
6. Novel αO-conotoxin GeXIVA[1,2] Nonaddictive Analgesic with Pharmacokinetic Modelling-Based Mechanistic Assessment.
Zhu X; Yuan M; Wang H; Zhangsun D; Yu G; Che J; Luo S
Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145535
[TBL] [Abstract][Full Text] [Related]
7. Effects of serum, enzyme, thiol, and forced degradation on the stabilities of αO-Conotoxin GeXIVA[1,2] and GeXIVA [1,4].
Yu S; Wu Y; Xu P; Wang S; Zhangsun D; Luo S
Chem Biol Drug Des; 2018 May; 91(5):1030-1041. PubMed ID: 29316361
[TBL] [Abstract][Full Text] [Related]
8. The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain.
Wang H; Li X; Zhangsun D; Yu G; Su R; Luo S
Mar Drugs; 2019 May; 17(5):. PubMed ID: 31060282
[TBL] [Abstract][Full Text] [Related]
9. Anti-hypersensitive effect of intramuscular administration of αO-conotoxin GeXIVA[1,2] and GeXIVA[1,4] in rats of neuropathic pain.
Li X; Hu Y; Wu Y; Huang Y; Yu S; Ding Q; Zhangsun D; Luo S
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Apr; 66():112-119. PubMed ID: 26706456
[TBL] [Abstract][Full Text] [Related]
10. αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors.
Sun Z; Bao J; Zhangsun M; Dong S; Zhangsun D; Luo S
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32272701
[TBL] [Abstract][Full Text] [Related]
11. ɑO-Conotoxin GeXIVA isomers modulate N-type calcium (Ca
Yousuf A; Wu X; Bony AR; Sadeghi M; Huang YH; Craik DJ; Adams DJ
J Neurochem; 2022 Jan; 160(2):154-171. PubMed ID: 34738241
[TBL] [Abstract][Full Text] [Related]
12. Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
Halai R; Clark RJ; Nevin ST; Jensen JE; Adams DJ; Craik DJ
J Biol Chem; 2009 Jul; 284(30):20275-84. PubMed ID: 19447885
[TBL] [Abstract][Full Text] [Related]
13. Backbone cyclization of analgesic conotoxin GeXIVA facilitates direct folding of the ribbon isomer.
Wu X; Huang YH; Kaas Q; Harvey PJ; Wang CK; Tae HS; Adams DJ; Craik DJ
J Biol Chem; 2017 Oct; 292(41):17101-17112. PubMed ID: 28851841
[TBL] [Abstract][Full Text] [Related]
14. Differential Expression of Nicotine Acetylcholine Receptors Associates with Human Breast Cancer and Mediates Antitumor Activity of αO-Conotoxin GeXIVA.
Sun Z; Zhangsun M; Dong S; Liu Y; Qian J; Zhangsun D; Luo S
Mar Drugs; 2020 Jan; 18(1):. PubMed ID: 31963558
[TBL] [Abstract][Full Text] [Related]
15. Orthosteric and/or Allosteric Binding of α-Conotoxins to Nicotinic Acetylcholine Receptors and Their Models.
Kryukova EV; Ivanov IA; Lebedev DS; Spirova EN; Egorova NS; Zouridakis M; Kasheverov IE; Tzartos SJ; Tsetlin VI
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30469507
[TBL] [Abstract][Full Text] [Related]
16. αO-Conotoxin GeXIVA[1,2] Reduced Neuropathic Pain and Changed Gene Expression in Chronic Oxaliplatin-Induced Neuropathy Mice Model.
Wang H; Li X; Qiao Y; Wang M; Wang W; McIntosh JM; Zhangsun D; Luo S
Mar Drugs; 2024 Jan; 22(1):. PubMed ID: 38276651
[TBL] [Abstract][Full Text] [Related]
17. Lyophilization Serves as an Effective Strategy for Drug Development of the α9α10 Nicotinic Acetylcholine Receptor Antagonist α-Conotoxin GeXIVA[1,2].
Li Z; Han X; Hong X; Li X; Gao J; Zhang H; Zheng A
Mar Drugs; 2021 Feb; 19(3):. PubMed ID: 33668830
[TBL] [Abstract][Full Text] [Related]
18. Oligoarginine Peptides, a New Family of Nicotinic Acetylcholine Receptor Inhibitors.
Lebedev DS; Kryukova EV; Ivanov IA; Egorova NS; Timofeev ND; Spirova EN; Tufanova EY; Siniavin AE; Kudryavtsev DS; Kasheverov IE; Zouridakis M; Katsarava R; Zavradashvili N; Iagorshvili I; Tzartos SJ; Tsetlin VI
Mol Pharmacol; 2019 Nov; 96(5):664-673. PubMed ID: 31492697
[TBL] [Abstract][Full Text] [Related]
19. α-Conotoxin Vc1.1 Structure-Activity Relationship at the Human α9α10 Nicotinic Acetylcholine Receptor Investigated by Minimal Side Chain Replacement.
Chu X; Tae HS; Xu Q; Jiang T; Adams DJ; Yu R
ACS Chem Neurosci; 2019 Oct; 10(10):4328-4336. PubMed ID: 31411453
[TBL] [Abstract][Full Text] [Related]
20. Interaction of rat α9α10 nicotinic acetylcholine receptor with α-conotoxin RgIA and Vc1.1: Insights from docking, molecular dynamics and binding free energy contributions.
Li R; Li X; Jiang J; Tian Y; Liu D; Zhangsun D; Fu Y; Wu Y; Luo S
J Mol Graph Model; 2019 Nov; 92():55-64. PubMed ID: 31330438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
